Private company

Radius Health, Inc.

American pharmaceutical preparations company based in Boston, active since 2008.

Last updated Oct 18, 2026.

Overview

IndustryPharmaceutical Preparations
HeadquartersBoston, United States
Incorporated inDE²
Business addressAttn: Principal Finance Officer, 22 Boston Wharf Road, 7Th Floor, Boston, Ma 02210²
Filer categoryLarge accelerated filer²

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

-23.6%Operating margin³

-30.5%Net margin³

-3.6%Revenue growth, 2021³

-$22.5MFree cash flow³

Where the money goes

Where each dollar of revenue went, fiscal 2021

Research and developmentSelling, general and admin

Research and development48¢$134.6M
Selling, general and admin46¢$130.5M
Interest6¢$18.3M

Out of $230.0M in revenue.³ The company lost money this year.

Financial statements

Revenue⁴⁵³$230.0M in 2021

Operating income⁴⁶⁷⁵³-$54.3M in 2021−45% since 2015

Net income⁴⁶⁷⁵³-$70.2M in 2021−31% since 2015

Fiscal year	2015	2016	2017	2018	2019	2020	2021
Revenue	$0⁴	$0⁴	$12.1M⁴	$99.2M⁵	$173.3M³	$238.6M³	$230.0M³
Cost of revenue		$0⁶	$932.0K⁶	$7.6M⁶
Research and development	$68.3M⁴	$107.4M⁶	$83.1M⁷	$99.9M⁵	$116.8M³	$159.7M³	$134.6M³
Selling, general and admin					$152.7M³	$144.2M³	$130.5M³
Operating income	-$99.1M⁴	-$184.9M⁶	-$249.0M⁷	-$204.1M⁵	-$112.2M³	-$82.4M³	-$54.3M³
Interest	$1.9M⁴	$0⁶	$8.3M⁷	$23.0M⁵	$24.9M³	$28.0M³	$18.3M³
Income tax	$0⁴	$0⁶	$0⁷	$0⁵	$0³	$0³	$0³
Net income	-$101.5M⁴	-$182.8M⁶	-$254.2M⁷	-$221.3M⁵	-$133.0M³	-$109.2M³	-$70.2M³
Earnings per share					-$2.89³	-$2.35³	-$1.49³
Earnings per share (diluted)					-$2.89³	-$2.35³	-$1.49³

Total assets¹⁰⁴⁶⁷⁵³$181.5M in 2021−62% since 2015

Total liabilities¹⁰⁴⁶⁷⁵³$433.8M in 2021+1948% since 2015

Shareholders’ equity⁶⁷⁵³-$252.3M in 2021

Cash⁶⁷⁵³$111.5M in 2021−30% since 2015

Long-term debt⁴⁶⁷$195.6M in 2019

Fiscal year	2015	2016	2017	2018	2019	2020	2021
Cash	$159.7M⁶	$258.6M⁶	$118.6M⁶	$59.3M⁷	$69.9M⁵	$91.4M³	$111.5M³
Current assets	$480.3M¹⁰	$334.8M⁴	$269.5M⁶	$275.0M⁷	$203.1M⁵	$180.5M³	$173.1M³
Total assets	$482.5M¹⁰	$340.3M⁴	$461.7M⁶	$287.0M⁷	$219.2M⁵	$191.6M³	$181.5M³
Current liabilities	$21.2M¹⁰	$32.7M⁴	$53.4M⁶	$46.4M⁷	$61.3M⁵	$73.2M³	$94.8M³
Long-term debt		$0⁴	$166.0M⁶	$179.8M⁷	$195.6M⁷
Total liabilities	$21.2M¹⁰	$33.1M⁴	$219.6M⁶	$226.3M⁷	$261.4M⁵	$315.2M³	$433.8M³
Shareholders’ equity	$461.3M⁶	$307.2M⁷	$242.0M⁵	$60.6M³	-$42.3M³	-$123.7M³	-$252.3M³
Shares outstanding	43.0M shares¹⁰	43.1M shares⁴	44.6M shares⁶	45.6M shares⁷	46.2M shares⁵	46.8M shares³	47.4M shares³

Cash from operations⁴⁶⁷⁵³-$22.4M in 2021−74% since 2015

Capital spending⁴⁶⁷⁵³$28.0K in 2021−98% since 2015

Free cash flow⁴⁶⁷⁵³-$22.5M in 2021−75% since 2015

Fiscal year	2015	2016	2017	2018	2019	2020	2021
Cash from operations	-$87.1M⁴	-$139.8M⁶	-$206.7M⁷	-$204.7M⁵	-$82.4M³	-$73.9M³	-$22.4M³
Capital spending	$1.2M⁴	$2.9M⁶	$2.3M⁷	$185.0K⁵	$0³	$0³	$28.0K³
Free cash flow	-$88.3M	-$142.7M	-$209.0M	-$204.9M	-$82.4M	-$73.9M	-$22.5M

Compare Radius Health, Inc. with another company

Leadership

Who has led Radius Health, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Chief financial officer

2010201520202025

Chief executive officerG. Kelly Martin Apr 29, 2020 to Aug 15, 2022¹¹
Chief executive officerJesper Hoiland Jul 18, 2017 to Feb 24, 2020¹²
Chief executive officerDrew J. Fromkin Nov 18, 2013 to Nov 18, 2013¹³
Chief executive officerMichael S. Wyzga Apr 20, 2012 to Jun 22, 2012¹⁴
Chief executive officerCecil Richard Lyttle Apr 29, 2011 to Nov 8, 2011¹⁵
PresidentG. Kelly Martin Apr 29, 2020 to Aug 15, 2022¹¹
PresidentJesper Hoiland Jul 18, 2017 to Feb 24, 2020¹²
PresidentDrew J. Fromkin Nov 18, 2013 to Nov 18, 2013¹³
PresidentCecil Richard Lyttle Apr 29, 2011 to Dec 6, 2013¹⁵
PresidentPeter Steven St Jun 16, 2008 to Jun 16, 2008¹⁶
Chief financial officerMark William Conley Mar 17, 2022 to Mar 17, 2022¹⁷
Chief financial officerJose Carmona May 16, 2017 to Feb 28, 2020¹⁸
Chief financial officerBrian Nicholas Harvey Apr 29, 2011 to Apr 27, 2017¹⁹

Board members and other officers (44)

Senior Vice PresidentElizabeth Messersmith Feb 28, 2022 to Aug 15, 2022²⁰
Chief Business OfficerChhaya Shah Mar 24, 2021 to Aug 15, 2022²¹
Principal Financial OfficerSteven Helwig Aug 26, 2021 to Jan 25, 2022²²
Vice President, SalesDanielle Holtschlag Sep 23, 2021 to Aug 15, 2022²³
OfficerDan Dolan Oct 6, 2020 to Nov 10, 2020²⁴
Chief Commercial OfficerSal Grausso Nov 10, 2020 to Feb 26, 2021²⁵
Principal Finance AccountingJames George Chopas Dec 18, 2020 to Mar 9, 2021²⁶
Chief Medical OfficerCharles Q. Morris Sep 5, 2018 to Feb 28, 2020²⁷
SVP,Global Oncology/CommercialDinesh Purandare Mar 19, 2015 to Feb 22, 2017²⁸
Sr.Vice President, Gen.CounselBrent Hatzis-Schoch Apr 30, 2015 to Apr 30, 2015²⁹
Chief Medical OfficerLorraine A. Fitzpatrick Jul 29, 2015 to Feb 13, 2019³⁰
Chief Commercial OfficerDavid P. Snow Sep 11, 2015 to Feb 6, 2018³¹
Chief Development OfficerGregory C. Williams Jan 16, 2014 to Feb 15, 2018³²
Chief Commercial OfficerMark Durand May 5, 2014 to Jun 9, 2014³³
Chief Medical OfficerLouis Brenner Md. Apr 20, 2012 to Sep 28, 2012³⁴
Sr. Vice President and CBOMichael Franken Jun 19, 2012 to Jun 19, 2012³⁵
Vice President, BiologyGary Hattersley May 19, 2011 to Feb 13, 2019³⁶
Sr VP, Chief Medical OfficerLouis O'Dea May 19, 2011 to Nov 8, 2011³⁷
SecretaryVort John Vander Jun 16, 2008 to Jun 16, 2008³⁸
Board memberJennifer Jarrett May 20, 2022 to Aug 15, 2022³⁹
Board memberSusan Vissers Lisa May 20, 2022 to Aug 15, 2022⁴⁰
Board memberEschenbach Andrew C. Von Jan 5, 2021 to Aug 15, 2022⁴¹
Board memberMachelle Sanders Jan 5, 2021 to Aug 15, 2022⁴²
Board memberG. Kelly Martin Apr 29, 2020 to Aug 15, 2022¹¹
Board memberJessica Hopfield Jan 25, 2019 to Feb 24, 2020⁴³
Board memberJesper Hoiland Jul 18, 2017 to Feb 24, 2020¹²
Board memberAnthony Rosenberg Mar 3, 2015 to Feb 28, 2020⁴⁴
Board memberDebasish Roychowdhury Jul 20, 2015 to Apr 12, 2019⁴⁵
Board memberCathy Friedman Aug 19, 2015 to Aug 15, 2022⁴⁶
Board memberGregory C. Williams Feb 19, 2014 to Feb 19, 2014⁴⁷
Board memberWillard H. Dere Nov 7, 2014 to Aug 15, 2022⁴⁸
Board memberMorana Jovan-Embiricos May 3, 2013 to Jan 20, 2015⁴⁹
Board memberOwen Hughes May 3, 2013 to Aug 15, 2022⁵⁰
Board memberDrew J. Fromkin Nov 18, 2013 to Nov 18, 2013¹³
Board memberMichael S. Wyzga Apr 20, 2012 to Jun 22, 2012¹⁴
Board memberAlan H. Auerbach May 19, 2011 to Feb 22, 2017⁵¹
Board memberAnsbert Gadicke May 19, 2011 to Feb 22, 2017⁵²
Board memberCecil Richard Lyttle May 19, 2011 to Nov 8, 2011⁵³
Board memberElizabeth Stoner May 19, 2011 to Dec 19, 2014⁵⁴
Board memberKurt Graves May 19, 2011 to Feb 24, 2020⁵⁵
Board memberMartin Muenchbach May 19, 2011 to May 26, 2015⁵⁶
Board memberPeter Steven St Jun 16, 2008 to Jun 16, 2008¹⁶
Board memberVort John Vander Jun 16, 2008 to Jun 16, 2008³⁸
General counselBrent Hatzis-Schoch Apr 1, 2015 to Feb 26, 2019⁵⁷

Former names

MPM ACQUISITION CORPApr 16, 2008 to May 13, 2011²

Timeline

Apr 29, 2020New chief executive G. Kelly Martin becomes CEO¹¹
Jul 18, 2017New chief executive Jesper Hoiland becomes CEO¹²
Nov 18, 2013New chief executive Drew J. Fromkin becomes CEO¹³
Apr 20, 2012New chief executive Michael S. Wyzga becomes CEO¹⁴
Apr 29, 2011New chief executive Cecil Richard Lyttle becomes CEO¹⁵
Feb 4, 2008Founded Radius Health, Inc. is founded⁵⁸

Filings

126 filings to the SEC since October 2021: 2 annual reports, 3 quarterly reports, 16 major events, 43 insider forms, 18 large holders, 44 other. The latest 20:

Aug 30, 2022SC 13D/A EDGAR
Aug 30, 20224 FORM 4 SUBMISSION EDGAR
Aug 26, 2022SC 13D/A AMENDMENT NO. 5 TO THE SCHEDULE 13D EDGAR
Aug 25, 202215-12G EDGAR
Aug 17, 2022SC 13G EDGAR
Aug 15, 20228-K EDGAR
Aug 15, 2022S-8 POS EDGAR
Aug 15, 2022S-8 POS EDGAR
Aug 15, 2022S-8 POS EDGAR
Aug 15, 2022S-8 POS EDGAR
Aug 15, 2022S-8 POS EDGAR
Aug 15, 2022S-8 POS EDGAR
Aug 15, 2022S-8 POS EDGAR
Aug 15, 2022S-8 POS EDGAR
Aug 15, 2022S-8 POS EDGAR
Aug 15, 20224 FORM 4 SUBMISSION EDGAR
Aug 15, 20224 FORM 4 SUBMISSION EDGAR
Aug 15, 20224 FORM 4 SUBMISSION EDGAR
Aug 15, 20224 FORM 4 SUBMISSION EDGAR
Aug 15, 20224 FORM 4 SUBMISSION EDGAR

The 126 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 18 such filings since October 2021, the latest 10:

Aug 30, 2022SC 13D/A
Aug 26, 2022SC 13D/A
Aug 17, 2022SC 13G
Jul 12, 2022SC 13D/A
Jul 11, 2022SC 13G/A
Jun 16, 2022SC 13D
May 25, 2022SC 13D/A
Apr 18, 2022SC 13D/A
Mar 15, 2022SC 13D/A
Mar 7, 2022SC 13D

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRadius Health, Inc. filings on SEC EDGAR
2
SEC EDGARRadius Health, Inc. filings on SEC EDGAR
3
SEC EDGARRadius Health, Inc. 10-K for fiscal 2021
4
SEC EDGARRadius Health, Inc. 10-K for fiscal 2015
5
SEC EDGARRadius Health, Inc. 10-K for fiscal 2018
6
SEC EDGARRadius Health, Inc. 10-K for fiscal 2016
7
SEC EDGARRadius Health, Inc. 10-K for fiscal 2017
8
SEC EDGARRadius Health, Inc. 10-Q for fiscal 2022
9
SEC EDGARRadius Health, Inc. 10-Q for fiscal 2022
10
SEC EDGARRadius Health, Inc. 10-K for fiscal 2015
11
SEC EDGARG. Kelly Martin, Chief executive officer
12
SEC EDGARJesper Hoiland, Chief executive officer
13
SEC EDGARDrew J. Fromkin, Chief executive officer
14
SEC EDGARMichael S. Wyzga, Chief executive officer
15
SEC EDGARCecil Richard Lyttle, Chief executive officer
16
SEC EDGARPeter Steven St, President
17
SEC EDGARMark William Conley, Chief financial officer
18
SEC EDGARJose Carmona, Chief financial officer
19
SEC EDGARBrian Nicholas Harvey, Chief financial officer
20
SEC EDGARElizabeth Messersmith, Senior Vice President
21
SEC EDGARChhaya Shah, Chief Business Officer
22
SEC EDGARSteven Helwig, Principal Financial Officer
23
SEC EDGARDanielle Holtschlag, Vice President, Sales
24
SEC EDGARDan Dolan, Officer
25
SEC EDGARSal Grausso, Chief Commercial Officer
26
SEC EDGARJames George Chopas, Principal Finance Accounting
27
SEC EDGARCharles Q. Morris, Chief Medical Officer
28
SEC EDGARDinesh Purandare, SVP,Global Oncology/Commercial
29
SEC EDGARBrent Hatzis-Schoch, Sr.Vice President, Gen.Counsel
30
SEC EDGARLorraine A. Fitzpatrick, Chief Medical Officer
31
SEC EDGARDavid P. Snow, Chief Commercial Officer
32
SEC EDGARGregory C. Williams, Chief Development Officer
33
SEC EDGARMark Durand, Chief Commercial Officer
34
SEC EDGARLouis Brenner Md., Chief Medical Officer
35
SEC EDGARMichael Franken, Sr. Vice President and CBO
36
SEC EDGARGary Hattersley, Vice President, Biology
37
SEC EDGARLouis O'Dea, Sr VP, Chief Medical Officer
38
SEC EDGARVort John Vander, Secretary
39
SEC EDGARJennifer Jarrett, Board member
40
SEC EDGARSusan Vissers Lisa, Board member
41
SEC EDGAREschenbach Andrew C. Von, Board member
42
SEC EDGARMachelle Sanders, Board member
43
SEC EDGARJessica Hopfield, Board member
44
SEC EDGARAnthony Rosenberg, Board member
45
SEC EDGARDebasish Roychowdhury, Board member
46
SEC EDGARCathy Friedman, Board member
47
SEC EDGARGregory C. Williams, Board member
48
SEC EDGARWillard H. Dere, Board member
49
SEC EDGARMorana Jovan-Embiricos, Board member
50
SEC EDGAROwen Hughes, Board member
51
SEC EDGARAlan H. Auerbach, Board member
52
SEC EDGARAnsbert Gadicke, Board member
53
SEC EDGARCecil Richard Lyttle, Board member
54
SEC EDGARElizabeth Stoner, Board member
55
SEC EDGARKurt Graves, Board member
56
SEC EDGARMartin Muenchbach, Board member
57
SEC EDGARBrent Hatzis-Schoch, General counsel
58
gleifRadius Health, Inc. is founded